CHIPP Profiling Expansion Momentum's CHIPP technology launch enables scalable and comprehensive target profiling, offering clients a faster path to map target classes and prioritize leads; creates cross-sell opportunities into existing MS-based discovery services.

Proteomics Expansion Acquisition of OmicScouts GmbH brings proteomics leadership and expanded MS capabilities, enabling integrated proteomics workflows and deeper data for client programs; unlocks cross-sell opportunities with current clients seeking proteomics-driven discovery.

High Throughput MS The RapidFire high-throughput MS platform and a large instrument lab support rapid data turnaround and scalable screening for degraders, molecular glues, PPIs, and other target classes, helping clients accelerate decision-making.

Strategic Partnerships Strategic collaborations and new SAB additions from OmicScouts and Axxam strengthen Momentum's credibility and expand selling avenues, enabling co-selling with biotech and pharma partners seeking established MS-based discovery capabilities.

Diverse Target Coverage Momentum focuses on degraders, molecular glues, PPIs, RNA binders and related targets, using ASMS, intact mass MS, chemoproteomics and small molecule analyses to offer end-to-end discovery support and upsell across stages.